Do treatment effects vary among differing baseline depression criteria in depression in Alzheimer's disease study ± 2 (DIADS-2)?
- 7 April 2011
- journal article
- research article
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 26 (6), 573-583
- https://doi.org/10.1002/gps.2565
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Sertraline for the Treatment of Depression in Alzheimer Disease: Week-24 OutcomesAmerican Journal of Geriatric Psychiatry, 2010
- Sertraline for the Treatment of Depression in Alzheimer DiseaseAmerican Journal of Geriatric Psychiatry, 2010
- Efficacy of Second Generation Antidepressants in Late-Life Depression: A Meta-Analysis of the EvidenceAmerican Journal of Geriatric Psychiatry, 2008
- Point and 5‐year period prevalence of neuropsychiatric symptoms in dementia: the Cache County StudyInternational Journal of Geriatric Psychiatry, 2007
- Clinical application of operationalized criteria for ?Depression of Alzheimer's Disease?International Journal of Geriatric Psychiatry, 2005
- Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Sertraline in the Treatment of Depression Complicating Alzheimer’s Disease: Initial Results From the Depression in Alzheimer’s Disease StudyAmerican Journal of Psychiatry, 2000
- Validity and Reliability of the Alzheimerʼs Disease Cooperative Study-Clinical Global Impression of ChangeAlzheimer Disease & Associated Disorders, 1997
- Multiple Imputation After 18+ YearsJournal of the American Statistical Association, 1996
- Moclobemide in Elderly Patients with Cognitive Decline and Depression: An International Double-blind, Placebo-controlled TrialThe British Journal of Psychiatry, 1996
- “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinicianJournal of Psychiatric Research, 1975